2014-2021 Psychiatry Sale Collection | Full access to more than 780 transaction records signed by the world’s leading pharmaceutical and biotech companies – QNT Press Release


Dublin, December 9, 2021 (Global News Service) – “Global Psychiatry Cooperation 2014-2021: Transaction Trends, Participants and Finances” Report has been added to ResearchAndMarkets.com supply.

Global Psychiatry Partnering 2014 to 2021 provides a complete collection of psychiatric transactions signed between the world’s pharmaceutical and biotech companies since 2014.

  • Trends in psychiatric transactions in the biopharmaceutical industry since 2014
  • Analysis of psychiatric transaction structure
  • Access title, pre-period, milestone and royalty data
  • Access hundreds of psychiatric transaction contract documents
  • Full access to more than 780 psychiatric transaction records
  • Leading psychiatric deal by value since 2014
  • The most active psychiatric dealer since 2014

Report scope

Global Psychiatry Partnering 2014 to 2021 aims to provide readers with an in-depth understanding and understanding of psychiatric trends and transaction structures reached by leading global companies.

The report includes transactions for the following indications: akathisia, anxiety disorder, generalized anxiety disorder, panic disorder, post-traumatic stress disorder, attention deficit hyperactivity disorder, bipolar disorder, chronic fatigue syndrome, cognitive impairment, Delirium, dementia, Alzheimer’s disease, Louis Vuitton dementia body, vascular dementia, depression, dystonia, eating disorders, anorexia, bulimia, learning disabilities, Asperger’s disease, self Autism, mania, obsessive-compulsive disorder, personality disorder, schizophrenia, sleep disorders, insomnia, narcolepsy, sleep apnea, tardive dyskinesia, Tourette’s disease and other psychiatric symptoms.

In the 2014 global psychiatric cooperation…

The full story can be found on Benzinga.com


Source link

Recommended For You

About the Author: News Center